BLIS K12 AND PROBIOTICS
What is a probiotic?
| |
BUY NOW |
| |
| |
Watch this great video by International Probiotics Association (IPA). BLIS Technologies is a member of IPA.
Do you consume yogurt regularly? While not all yogurts contain probiotics, in consuming yogurt you will have consumed bacteria in these products .
If you have, then you have consumed live bacteria because yogurt is produced by the fermentation of milk by bacteria. Our focus is on beneficial bacteria, similar to those found in yogurt.
The definition of a probiotic adopted by the World Health Organisation is "Live microorganisms which when administered in adequate amounts confer a health benefit on the host”.
In simpler words, it means that probiotics are live beneficial bacteria that when consumed can have health benefits.
Most probiotics target the intestinal tract whereas BLIS K12™ probiotic is the world’s only probiotic for mouth and throat.
BLIS is an acronym for Bacteriocin Like Inhibitory Substances. Only certain bacteria produce BLIS, which are natural antibacterial agents that can be used to help control the undesirable bacterial implicated in diseases.
Let us introduce to you "Streptococcus salivarius K12". We call it "BLIS K12".
It is the world’s first bacterial replacement probiotic derived from the oral cavity for specific application to the oral cavity and upper respiratory tract.
Professor John Tagg from the University of Otago, New Zealand discovered BLIS K12™. He was looking for protective bacteria in the mouth that could prevent sore throats which can result in complications such as rheumatic fever in children. After studying Dunedin schoolchildren for many years, he found that some children didn't appear to get sore throats as often as others.
When he analysed their saliva Professor Tagg found that the children getting less sore throats appeared to have certain types of bacteria in their saliva that the other schoolchildren did not have (Dierksen and Tagg 2000). These were BLIS producing bacteria or bacteria that produced natural antimicrobials. One of these was a strain called S.salivarius K12. Streptococcus salivarius are common in the mouth and account for 40% of all the bacteria in the normal healthy mouth. Streptococcus salivarius K12 actually produces two powerful anti-microbial BLIS proteins, that inhibit encroaching deleterious bacteria, rupturing the cell wall and thus stopping the multiplication of the bad bacteria (Wescombe et al 2006, Hyink et al 2006).
Some 2% of the population are naturally protected as they already have Streptococcus salivarius producing bacteriocins similar to BLIS K12™ (Burton et al). However, for the large majority that do not have this natural protection, BLIS K12™ may offer significant benefits.

